List of largest biotechnology & pharmaceutical companies

From Wikipedia, the free encyclopedia
  (Redirected from List of biotechnology companies)
Jump to: navigation, search

The following is a list of the top 25 independent biotechnology companies listed on a stock exchange (as indicated) ranked by market capitalization. Note that it does not include biotechnology companies that are now owned by, or part of, larger pharmaceutical groups.

Rankings[edit]

Rank[N 1] Company Largest Market Cap (USD billions) Market Cap in Q2 2017 (USD billions) Market Cap in 2016 (USD billions)[1][2] Market Cap in 2015 (USD billions)[3] Market Cap in 2014 (USD billions)[4] Market Cap in 2013 (USD billions)
1 Steady United States Johnson & Johnson[P]
NYSEJNJ
367.5 (June 2017) 356.1 Increase 314.1 284.2 277.8 258.3
2 Steady Switzerland Roche[P]
OTCQXRHHBY
263.6 (Feb 2014) 216.7 Decrease 192.1 234.7 258.5 240.3
3 Steady United States Pfizer[P]
NYSEPFE
310.5 (Jul 2000) 200.5 Decrease 196.3 199.3 205.4 196.0
4 Steady Switzerland Novartis[P]
NYSENVS
275.2 (Jul 2015) 197.5 Increase 170.5 206.1 229.8 195.0
5 Steady United States Merck & Co.[P]
NYSEMRK
182.8 (Mar 2017) 175.3 Increase 164.3 147.6 166.9 146.5
6 Steady United States AmgenB
NASDAQAMGN
134.5 (Mar 2017) 126.7 Increase 108.9 122.5 93.1 78.7
7 Steady France Sanofi[P]
NYSESNY
151.3 (Sep 2014) 123.8 Increase 101.8 111.8 138.1 142.0
8 Steady United States AbbVie[P]
NYSEABBV
117.9 Jul 2015 115.4 Increase 100.2 96.8 104.1 83.8
9 Increase9 Denmark Novo Nordisk[P]
NYSENVO
159.6 (Aug 2015) 109.4 Increase 92.6 153.9 125.4 19.6
10 Increase1 Germany BayerB
FWBBAYN
129.0 (Mar 2015) 107.4 Increase 85.3 103.2 113.2 117.4
11 Decrease2 United Kingdom GlaxoSmithKline[P]
NYSEGSK
174.9 (May 2006) 106.0 Increase 93.3 97.6 128.9 129.6
12 Decrease2 United States CelgeneB
NASDAQCELG
110.0 Jul 2015 101.4 Increase 91.4 94.1 89.5 69.2
13 Steady United States Gilead SciencesB
NASDAQGILD
179.6 (Jun 2013) 92.5 Increase 96.6 145.8 109.0 78.4
14 Steady United States Bristol-Myers Squibb[P]
NASDAQBMY
128.3 (Jul 2016) 91.8 Increase 98.2 114.8 97.6 87.2
15 Decrease3 United States Eli Lilly & Co[P]
NYSELLY
122.6 (Aug 2000) 90.8 Decrease 80.9 93.4 76.6 57.0
16 Steady United Kingdom AstraZeneca[P]
NYSEAZN
102.9 (Oct 2006) 86.3 Increase 68.8 85.8 88.9 74.6
17 Steady United States Abbott Laboratories[P]
NYSEABT
85.5 (June 2017) 84.4 Increase 56.4 67.0 67.9 59.3
18 Decrease3 Republic of Ireland Allergan[P]
NYSEAGN
133.5 (Jul 2015) 81.6 Increase 72.7 123.3 68.5 29.3
19 Steady United States Biogen[P]
NASDAQBIIB
111.7 (Mar 2015) 57.6 Decrease 61.6 68.3 79.7 66.1
20 Increase2 United States Regeneron Pharmaceuticals Inc[P]
NASDAQREGN
61.4 (Aug 2015) 52.2 Increase 39.3 56.5 42.0 27.4
21 Steady United States Stryker Corporation[P]
NYSESYK
54.1 (June 2017) 51.9 Increase 45.1 34.7 35.7 28.4
22 Decrease2 United States Shire Pharmaceuticals[P]
NASDAQSHPG
62.0 (Sep 2014) 50.0 Decrease 50.1 41.0 42.4 28.1
23 Steady Israel Teva Pharmaceutical[P]
NYSETEVA
60.4 (Jul 2015) 33.8 Increase 37.5 55.9 49.0 37.8
24 Steady United States Vertex Pharmaceuticals[P]
NASDAQVRTX
34.6 (Aug 2015) 32.1 Increase 18.3 31.0 28.7 17.4
25 Steady United States Zoetis[P]
NASDAQALXN
31.2 (June 2017) 30.6 Increase 26.4 23.8 21.6 16.3

Footnotes[edit]

  1. ^ The change is the companies' relative position in this list, compared to their relative position in the prior year; i.e, an increase would be moving closer to rank 1 and vice-versa
  • B – Biotechnology company
  • P – Pharmaceutical company

Graphical representation[edit]

Graphical representation of the top-25 Biotechnology companies sorted by market capitalisation for Q2 of 2017

See also[edit]

References[edit]